Supplement of exogenous IL2 abrogates induction of tolerance in drug-induced T cell proliferation.
D000818:Animals; D002478:Cells, Cultured; D007108:Immune Tolerance / Q000187:drug effects*; D007114:Immunization; D007376:Interleukin-2 / Q000008:administration & dosage* / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D013408:Sulbenicillin / Q000008:administration & dosage / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D006377:T-Lymphocytes, Helper-Inducer / Q000187:drug effects / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology
D007376:Interleukin-2; D013408:Sulbenicillin